2nd Quarter - Report

INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) for INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)

Firm
Client
Income
—
Expenses
$162,156
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Legislative and Regulatory Issues as they relate to compounding pharmacies: S. 959 and related bills

LobbyistCovered position, as disclosed
SARAH RYAN DODGE-PALMER —
STEVE IRIZARRY —
R DAVID PORE —
JIM TURNER —
RICH WHITE —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Health & Human Services, Dept of (HHS)

Bills named: S. 959 (113th)

Medicare/Medicaid MMM

Reimbursement Issues related to compounded pharmacy products and third-party coverages of those products

LobbyistCovered position, as disclosed
SARAH RYAN DODGE-PALMER —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Health Care Reform Act and Health Care Issues as they Impact Compounding Pharmacists

LobbyistCovered position, as disclosed
SARAH RYAN DODGE-PALMER —

Contacted: Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Law Enforcement/Crime/Criminal Justice LAW

DEA Issues as they relate to the Controlled Substances Act and pharmacies

LobbyistCovered position, as disclosed
SARAH RYAN DODGE-PALMER —
R DAVID PORE —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.